搜索临床试验以:TGRX-814
总计2123个结果
-
Shenzhen TargetRx, Inc.Institute of Hematology & Blood Diseases Hospital, China招聘中
-
Shenzhen TargetRx, Inc.The First Affiliated Hospital of Soochow University尚未招聘非小细胞肺癌
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer Center招聘中
-
Shenzhen TargetRx, Inc.Zhejiang Cancer Hospital; Sun Yat-sen University; Fujian Cancer Hospital; First Affiliated Hospital... 和其他合作者招聘中
-
Shenzhen TargetRx, Inc.Peking University People's Hospital尚未招聘
-
Shenzhen TargetRx, Inc.Peking University People's Hospital招聘中
-
National Taiwan University Hospital招聘中
-
Second Affiliated Hospital, School of Medicine,...TCRx Therapeutics Co.Ltd尚未招聘胃癌 | 胃食管结合部癌
-
TG Therapeutics, Inc.终止慢性淋巴细胞白血病 | 非霍奇金淋巴瘤美国
-
TG Therapeutics, Inc.完全的
-
Therapex Co., Ltd尚未招聘癌,非小细胞肺癌 | EGFR 突变晚期非小细胞肺癌
-
TG Therapeutics, Inc.SCRI Development Innovations, LLC完全的
-
H. Lee Moffitt Cancer Center and Research InstituteTG Therapeutics, Inc.终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销
-
Weill Medical College of Cornell UniversityTG Therapeutics, Inc.终止
-
University of NebraskaNational Cancer Institute (NCI)完全的
-
TG Therapeutics, Inc.终止
-
BayerNerre Therapeutics Ltd.完全的
-
Bayer完全的潮热 | 健康志愿者 | 作为女性和男性的性激素依赖性疾病的血管舒缩症状中国
-
Guy's and St Thomas' NHS Foundation TrustKing's College London; University of Oxford; Engineering and Physical Sciences Research Council...完全的
-
BayerNerre Therapeutics Ltd.完全的
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)撤销
-
Ripple Therapeutics Pty LtdNovotech (Australia) Pty Limited完全的
-
Medtronic Cardiac Rhythm and Heart FailureThe Cleveland Clinic完全的CIED相关感染荷兰, 美国, 意大利, 瑞士, 芬兰, 西班牙, 智利, 希腊, 法国, 以色列, 波兰, 新加坡, 加拿大, 德国, 葡萄牙, 中国, 瑞典, 英国, 比利时, 丹麦, 沙特阿拉伯, 奥地利, 马来西亚, 挪威, 斯洛伐克
-
Shenzhen TargetRx, Inc.The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School招聘中
-
Clinical Research Center, Intercard Sp. z o.o.Corindus, Inc. dba Siemens Healthineers Endovascular Robotics; KCRI Sp. z o.o.招聘中
-
TG Therapeutics, Inc.Memorial Sloan Kettering Cancer Center完全的
-
TG Therapeutics, Inc.主动,不招人